Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOFIA-LTT: Intermittent Pegasys in HBeAg-Negative Chronic Hepatitis B
NCT00442572Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2006
- Primary completion
- Apr 2012
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB), sponsored by Roche. Started Jul 2006; status: completed.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00442572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442572.